Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-07T09:26:35.221Z Has data issue: false hasContentIssue false

Electrophysiological and pharmacological characterization of K+-currents in muscle fibres isolated from the ventral sucker of Fasciola hepatica

Published online by Cambridge University Press:  18 November 2004

D. KUMAR
Affiliation:
Parasite Proteomics and Therapeutics Research Group, School of Biology and Biochemistry, The Queen's University of Belfast, Belfast BT9 7BL, Northern Ireland
C. WHITE
Affiliation:
Smooth Muscle Research Group, Department of Physiology, The Queen's University of Belfast, Belfast BT9 7BL, Northern Ireland
I. FAIRWEATHER
Affiliation:
Parasite Proteomics and Therapeutics Research Group, School of Biology and Biochemistry, The Queen's University of Belfast, Belfast BT9 7BL, Northern Ireland
J. G. McGEOWN
Affiliation:
Smooth Muscle Research Group, Department of Physiology, The Queen's University of Belfast, Belfast BT9 7BL, Northern Ireland
Rights & Permissions [Opens in a new window]

Abstract

Fibres isolated from the ventral sucker of Fasciola hepatica were identified as muscle on the basis of their contractility, and their actin and myosin staining. They were voltage-clamped at a holding potential of −40 mV and depolarization-activated outward currents were characterized both electrophysiologically and pharmacologically. Activation was well fitted by a Boltzmann equation with a half-maximal potential of +9 mV and a slope factor of −14·3 mV, and the kinetics of activation and deactivation were voltage-sensitive. Tail current analysis showed that the reversal potential was shifted by +46±3 mV when EK was increased by 52 mV, confirming that this was a K+-current with electrophysiological characteristics similar to delayed rectifier and Ca2+-activated K+-currents in other tissues. The peak current at +60 mV was inhibited by 76±6% by tetrapentylammonium chloride (1 mM) and by 84±7% by Ba2+ (3 mM), but was completely resistant to block by tetraethylammonium (30 mM), 3,4-diaminopyridine (100 μM) and 4-aminopyridine (10 mM). Penitrem A, a blocker of high-conductance Ca2+-activated K+-channels reduced the current at +60 mV by 23±5%. When the effects of Ca2+-channel blocking agents were tested, the peak outward current at +60 mV was reduced by 71±7% by verapamil (30 μM) and by 59±4% by nimodipine (30 μM). Superfusion with BAPTA-AM (50 μM), which is hydrolysed intracellularly to release the Ca2+-buffer BAPTA, also decreased the current by 44±16%. We conclude that voltage-and Ca2+-sensitive K+-channels are expressed in this tissue, but that their pharmacology differs considerably from equivalent channels in other phyla.

Information

Type
Research Article
Copyright
© 2004 Cambridge University Press
Figure 0

Fig. 1. Scanning electron micrographs of ventral sucker muscle from Fasciola hepatica. (A) Micrograph of a ventral sucker treated with potassium hydroxide and collagenase to reveal the muscle fibres in situ. The circumferential orientation of the underlying muscle is clearly seen on the exposed inner face of the sucker (outlined with a box). (B) Enlarged region from within the boxed area in (A) showing muscle fibres (large arrows) and their attached cell bodies (small arrowheads). (C) Individual muscle fibre isolated from the ventral sucker.

Figure 1

Fig. 2. Fluorescent staining for actin and myosin in ventral sucker from Fasciola hepatica. (A) Confocal optical section from ventral sucker stained for actin with TRITC-labelled phalloidin. (B) Confocal image of isolated fibres from ventral sucker labelled with TRITC-labelled phalloidin. (C) Confocal micrograph of a sucker labelled for myosin using a polyclonal antibody raised against type II myosin from Taenia solium and a FITC-conjugated secondary antibody. (D) Confocal images of isolated fibres labelled for myosin using the same antibodies.

Figure 2

Fig. 3. Step depolarizations from a holding potential of −40 mV evoked sustained outward currents in most muscle fibres studied. (A) Superimposed traces of the currents recorded from a single muscle fibre are shown below the applied voltage protocol. Depolarization was applied at 10 s intervals and increased in 10 mV steps from −40 mV to +60 mV. In this (and all other) records, the broken horizontal line represents zero current. (B) Plot of the mean values (±S.E.M.) of the peak current (filled symbols) and the sustained current (open symbols) at each membrane potential for 7 muscle fibres. (C) Data points represent the mean values of normalized whole cell conductance (G/Gmax) at each membrane potential (see text for details). The solid curve is a Boltzmann equation with half-maximal activation at 9 mV and a slope factor of −14·3 mV (R2 for fit=0·99). (D) Plot of the mean time-constant (τact) for activation of the outward current at each membrane potential used.

Figure 3

Fig. 4. Step depolarizations evoked more transient outward currents in a small percentage of muscle fibres studied. (A) Superimposed traces of the currents recorded from a single muscle fibre during voltage steps from −40 mV to +60 mV. The initial outward current decayed markedly during the maintained depolarizing step. (B) Plot of the mean values (±S.E.M.) of the peak current (filled symbols) and the sustained current (open symbols) evoked at each membrane potential for 7 fibres in which current decayed by more than 50% during the depolarizing step to +60 mV. (C) Voltage-dependent changes in the mean time-constant of activation (τact). (D) Voltage-dependent changes in the mean time-constant of current decay during depolarization to the potentials indicated (τdecay).

Figure 4

Fig. 5. [K+]o-dependence of tail-currents. (A) Muscle fibres were hyperpolarized to −80 mV for 10 ms and then depolarized to +60 mV for 200 ms to activate outward currents (see diagram of voltage-protocol). Repolarization to potentials varying between −120 mV and −10 mV elicited a family of tail-currents, as outlined by the boxes on the current records. All 3 sets of records were obtained from the same fibre at different [K+]o, as shown. (B) Tail-currents from A at higher amplification and on a faster time-base. (C) Mean tail-current (measured 6 ms after repolarization) plotted against membrane potential for 6 fibres exposed to the protocol in A under control conditions ([K+]o=4 mM, ellipsoid symbols; symbol size exceeds S.E.M. if no bar is shown) and with [K+]o=30 mM (rectangular symbols). Tail-current reversal potentials are indicated by arrows 1 and 2. (D) Voltage-dependence of the mean time-constants of deactivation (τdeact) for the tail currents under control conditions (filled symbols) and in high [K+]o (open symbols). No value has been plotted for high [K+]o at −20 mV as there was inadequate tail current under these conditions to allow accurate curve-fitting.

Figure 5

Fig. 6. Effects of K+ channel blockers on outward current. (A) Superimposed current records from a single fibre for depolarizations increased in 10 mV steps from −40 mV to +60 mV (see voltage protocol). The currents shown were recorded in control solutions (upper records) and during superfusion with 1 mM TPA+ (lower records). (B) Superimposed records showing the evolution of current blockade for a fibre that was depolarized to +60 mV every 30 s. The time elapsed from the start of TPA+ superfusion (1 mM) is shown. The sustained current was blocked more rapidly than the early current, leaving a residual transient outward current peak e.g., at 60 s. (C) Superimposed current records from a cell showing the current evoked during a step to +60 mV under control conditions and after 90 s superfusion with penitrem A (10 μM). (D) Bar charts summarizing the effects of different K+-channels blockers as assessed using the peak outward current evoked at +60 mV in the presence of the drug normalized to the control current in the same fibres. The concentrations and number of experiments summarized for each drug were as follows: TPA+ (1 mM; n=5), TEA+ (30 mM; n=5), Ba2+ (3 mM; n=4), penitrem A (10 μM; n=7), 3,4,DAP (100 μM; n=4) and 4AP (10 mM; n=8). Asterisks indicate statistically significant changes from paired controls; *P<0·05, **P<0·001 (paired t-test).

Figure 6

Fig. 7. Effects of verapamil on outward currents. (A) Superimposed records from a single fibre depolarized to +60 mV under control conditions and in the presence of increasing concentrations of verapamil. The sustained phase of current was selectively inhibited at the lower concentrations used. (B) Concentration-effect curve showing the mean ratio of the current amplitude at each verapamil concentration to the control current amplitude in the same fibre. Results for the peak and sustained currents are shown and each value represents the mean (±S.E.M.) for 6–8 fibres. (C) Superimposed currents recorded from a single fibre during step depolarizations increasing in 10 mV steps from −40 mV to +60 mV (see voltage protocol). The control currents (upper records) are compared with those recorded from the same cell during superfusion with 30 μM verapamil (lower records). (D) Summary of 5 experiments using the protocol in (C) showing mean values for the peak current at each membrane potential under control conditions (closed symbols) and in the presence of verapamil (open symbols).

Figure 7

Fig. 8. Effects of nimodipine on outward currents. (A) Current records from a single fibre depolarized to +60 mV under control conditions and in the presence of increasing concentrations of nimodipine. (B) Concentration-effect curve showing the mean ratio of the current amplitude at each nimodipine concentration to the control amplitude in the same fibre. Data for peak and sustained currents are summarized separately and each value represents the mean (±S.E.M.) for 6–7 fibres. (C) Superimposed currents recorded from a single fibre during a series of depolarizations increasing in 10 mV steps from −40 mV to +60 mV (see voltage protocol). The control currents (upper records) are compared with those recorded from the same fibre during superfusion with 30 μM nimodipine (lower records). (D) Summary of 5 experiments using the protocol in (C) showing mean values for the peak current at each membrane potential under control conditions (closed symbols) and in the presence of nimodipine (open symbols).

Figure 8

Fig. 9. (A) Two current records from the same fibre showing the current evoked during a step to +60 mV under control conditions and after 5 min superfusion with 50 μM BAPTA-AM. (B) Bar chart summarizing results from 5 experiments showing the effect of BAPTA-AM on the mean value (+S.E.M.) of the peak and sustained currents. P values indicate statistically significant reductions from control (paired t-test).